Lupus Nephritis (LN)

C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard Therapy

Neutrophil Extracellular Traps and Lupus Nephritis

Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)

Non Invasive Assessment of Subclinical Atherosclerosis and Cardiovascular Risk Using TYG Index in Lupus Nephritis

C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease

The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus Nephritis

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

Dapagliflozin in Active Lupus Nephritis

A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Research Accelerated by You Lupus Registry